Curated content that matters
Explore stories across diverse categories
President Lee Jae-myung sharply criticized POSCO Engineering & Construction (POSCO E&C) for a series of fatal workplace accidents,
Samsung Electronics, South Korea’s largest and globally leading manufacturer of smartphones, semiconductors, and consumer electronics, is accelerating efforts
Hyundai Motor Company, a leading South Korean automaker, sold nearly 1,000 electric vehicles in Indonesia during the first
South Korea’s POSCO International is entering India’s fast-growing solar energy market through a potential partnership with local renewable
(Photo=Hyundai) South Korea–based automaker Hyundai is facing a downturn in its U.S. hydrogen vehicle sales. Hyundai’s hydrogen-powered SUV, the NEXO, saw a significant sales decline in the U.S. during the first half of 2025, reflecting a broader slowdown in the hydrogen fuel cell electric vehicle (FCEV) market. Toyota’s Mirai, the NEXO’s main competitor, experienced an even steeper drop. According to
(Photo=Seegen) South Korea–based molecular diagnostics company Seegene is unveiling two of its most advanced innovations—CURECA™ and STAgora™—at ADLM 2025 in Chicago, marking a bold step toward redefining automation in diagnostic testing. From July 28 to 31, Seegene will showcase the world’s first fully automated PCR system, CURECA, and its companion global data analytics platform, STAgora, in their physical forms for
Photo=Kia Kia just pulled back the curtain on its game-changing PV5 electric vehicle, and it's not your average car. At their exclusive 'Tech Day' in Gwangmyeong, South Korea, the automaker revealed what might be the most customizable EV we've seen yet - a Swiss Army knife on wheels designed to transform how we think about personal and commercial transportation. The
Photo=HD Hyundai South Korea's HD Hyundai is positioning itself at the forefront of the maritime energy transition, unveiling its latest decarbonization strategy at the Electric & Hybrid Marine Expo Europe 2025 in Amsterdam. The company is betting on a hybrid combination of solid oxide fuel cells (SOFC) and bio-liquefied natural gas (Bio-LNG) to help the shipping industry meet tightening European
(Photo=Hanmi Pharmaceutical) Hanmi Pharmaceutical, a South Korea-based biopharmaceutical company, has introduced a novel immuno-oncology drug candidate, aiming to strengthen its position in the global pharmaceutical market with a fresh treatment approach. The company expects the new therapy to offer a paradigm shift in cancer care. On July 23, Hanmi announced the development of a YAP1/TEAD interaction inhibitor as its latest
